INS and sarcopenia: In other words, even if genetic PAM deficiency causes sarcopenia in the nondiabetic population, it seems plausible that long-term reduction of insulin secretion is the prime consequence of genetic PAM deficiency, causing an increase in the risk of diabetes and sarcopenia.